Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation

By Hracsko Zsuzsanna   Orvos Hajnalka   Novak Zoltan   Pal Attila   Varga Ilona S.  

Redox Report, Vol. 13, Iss. 1, 2008-02 ,pp. : 11-16

Maney Publishing

Access to resources Recommend Favorite

Intra-uterine Growth Retardation as a Risk Factor of Postnatal Metabolic Disorders

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 7, 2016-05 ,pp. : 587-596

Bentham Science Publishers

Access to resources Recommend Favorite

Intrauterine Growth Retardation is a Risk Factor for Cisapride-Induced QT Prolongation in Preterm Infants

By Corvaglia Luigi   Faldella Giacomo   Rotatori Raffaella   Lanari Marcello   Capretti Maria   Salvioli Gian  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 371-375

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab: Anhydramnios and fetal growth retardation following in utero exposure: case report

By  

Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Management of growth retardation in the young patient with Crohn’s disease

By Ballinger Anne  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite